Cargando…

Transparency and information sharing could help abate the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Rahimi, Farid, Talebi Bezmin Abadi, Amin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191256/ https://www.ncbi.nlm.nih.gov/pubmed/32319880 http://dx.doi.org/10.1017/ice.2020.174

Ejemplares similares

Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Tackling the COVID-19 Pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

The Ukrainian refugee crisis and the COVID-19 pandemic in Europe
por: Rahimi, Farid, et al.
Publicado: (2022)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

COVID-19 and science diplomacy
por: Rahimi, Farid, et al.
Publicado: (2022)

The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2021)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Mix Infections of Helicobacter pylori: A Major Risk Factor Affecting Genotyping Studies
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Updated Helicobacter pylori Management in 2015
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Type 2 diabetes and Helicobacter pylori infection: Starting point for the reality?
por: Abadi, Amin Talebi Bezmin
Publicado: (2015)

Comment on “Characteristics and Risk Factors of Helicobacter pylori Associated Gastritis: A Prospective Cross-Sectional Study in Northeast Thailand”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Bacteria in Cancer Therapy: Renaissance of an Old Concept”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Call for global vaccine instead of Helicobacter pylori blind antibiotic therapy
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat
por: Rahimi, Farid, et al.
Publicado: (2020)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

Comment on “Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon-γ Signaling”
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2015)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Omicron: A highly transmissible SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

Detection of the XE subvariant of SARS-CoV-2: A perspective
por: Rahimi, Farid, et al.
Publicado: (2022)

Implications of the SARS-CoV-2 subvariants BA.4 and BA.5
por: Rahimi, Farid, et al.
Publicado: (2022)

The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries
por: Rahimi, Farid, et al.
Publicado: (2022)

Corrigendum to ‘Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2’[Arch. Med. Res. 51(5) (2020) 453–454/ARCMED 2020 432]
por: Rahimi, Farid, et al.
Publicado: (2023)

Inefficiency of Rapid Urease Test for Confirmation of Helicobacter pylori
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2011)

Considerable use of Furazolidone in Iran
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2010)

Comment on “Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms”
por: Talebi Bezmin Abadi, Amin
Publicado: (2017)

Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer
por: Kamali, Negin, et al.
Publicado: (2022)

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
por: Darvishi, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1k8ialpibl8irm28kq0a3ghjvp